Bentley Cheatham

Title: The Innovations of Bentley Cheatham

Introduction

Bentley Cheatham is a notable inventor based in Durham, NC, who has made significant contributions to the field of medical science. With a focus on innovative treatments and diagnostic methods, he holds 2 patents that address critical health issues.

Latest Patents

One of Bentley Cheatham's latest patents is a method for treating post-prandial hypoglycemia. This invention discloses methods, sodium-dependent glucose transporter (SGLT)1 compounds, and compositions aimed at treating postprandial hypoglycemia, particularly in patients who have undergone gastric surgery. Another significant patent involves screening, diagnosing, treating, and prognosing pathophysiologic status through RNA regulation. This invention explores the relationship between cancer and ribonucleic acid (RNA) regulation, highlighting how intracellular levels of RNA regulators can impact cancer cell behavior. It suggests that effective clinical management strategies for uterine cell cancers can be developed by understanding the relationship between specific mRNAs and miRNAs.

Career Highlights

Throughout his career, Bentley Cheatham has worked with esteemed institutions such as University Hospitals Cleveland Medical Center and Rosalind Franklin University of Medicine and Science. His work in these organizations has allowed him to advance his research and contribute to the medical community.

Collaborations

Bentley has collaborated with notable colleagues, including George Gorodeski and Judith Ann Potashkin. These partnerships have further enriched his research and innovation efforts.

Conclusion

Bentley Cheatham's contributions to medical science through his patents and collaborations demonstrate his commitment to advancing healthcare solutions. His innovative approaches to treating complex health issues highlight the importance of research and development in the medical field.